Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gisslinger

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Leukemia|May 29, 2010
Deletions of the transcription factor Ikaros in myeloproliferative neoplasmsR Jäger, H Gisslinger, F Passamonti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Expression of the lung resistance protein predicts poor outcome in patients with multiple myelomaM Filipits, J Drach, G Pohl, et al.
British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.
Leukemia|November 9, 2000
Deletions of chromosome 13q in monoclonal gammopathy of undetermined significanceR Königsberg, J Ackermann, H Kaufmann, et al.
Annals of Hematology|April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center studyF Thalhammer, K Geissler, U Jäger, et al.
Leukemia|August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosisA Weltermann, I Pabinger, K Geissler, et al.
Blood|July 29, 1998
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapyJ Drach, J Ackermann, E Fritz, et al.
Blood|March 9, 2000
Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationN Zojer, R Königsberg, J Ackermann, et al.
Annals of Hematology|December 1, 1996
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemiaI M Huhmann, H H Watzke, K Geissler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Predictive role of interphase cytogenetics for survival of patients with multiple myelomaR Königsberg, N Zojer, J Ackermann, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Leukemia|May 29, 2010
Deletions of the transcription factor Ikaros in myeloproliferative neoplasmsR Jäger, H Gisslinger, F Passamonti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Expression of the lung resistance protein predicts poor outcome in patients with multiple myelomaM Filipits, J Drach, G Pohl, et al.
British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.
Leukemia|November 9, 2000
Deletions of chromosome 13q in monoclonal gammopathy of undetermined significanceR Königsberg, J Ackermann, H Kaufmann, et al.
Annals of Hematology|April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center studyF Thalhammer, K Geissler, U Jäger, et al.
Leukemia|August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosisA Weltermann, I Pabinger, K Geissler, et al.
Blood|July 29, 1998
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapyJ Drach, J Ackermann, E Fritz, et al.
Blood|March 9, 2000
Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationN Zojer, R Königsberg, J Ackermann, et al.
Annals of Hematology|December 1, 1996
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemiaI M Huhmann, H H Watzke, K Geissler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Predictive role of interphase cytogenetics for survival of patients with multiple myelomaR Königsberg, N Zojer, J Ackermann, et al.
Pageof 10